Literature DB >> 10752789

Dermatomyositis accompanied by rectal cancer: report of a case.

K Fujii1, Y Moriya, S Fujita, T Akasu, H Miyake, Y Nakanishi, T Saito.   

Abstract

Dermatomyositis (DM) is a rare inflammatory disorder of the skin and muscles associated with an increased incidence of malignancy. We describe herein the case of a 59-year-old woman with DM accompanied by rectal cancer. Following excision of the rectal cancer, the characteristic features of the skin rash such as the heliotrope eyelid rash and Gottron's papules, and proximal muscle weakness, improved. Moreover, the elevated preoperative serum levels of muscle-associated enzymes, including aspartate transaminase, creatine phosphokinase, lactate dehydrogenase, and aldolase, decreased from 38 to 16 (IU/1), 138 to 42 (IU/1), 672 to 515 (IU/1), and 32.2 to 4.3 (IU/1), respectively. The current concepts of the correlation between DM and malignancy are discussed with regard to the present case.

Entities:  

Mesh:

Year:  2000        PMID: 10752789     DOI: 10.1007/s005950050065

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  9 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.

Authors:  B Sigurgeirsson; B Lindelöf; O Edhag; E Allander
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

Review 3.  The spectrum of polymyositis and dermatomyositis.

Authors:  C M Pearson; A Bohan
Journal:  Med Clin North Am       Date:  1977-03       Impact factor: 5.456

4.  Survey of the prognosis for dermatomyositis, with special reference to its association with malignancy and pulmonary fibrosis.

Authors:  A Hidano; K Kaneko; Y Arai; R Kikuchi
Journal:  J Dermatol       Date:  1986-08       Impact factor: 4.005

5.  Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system.

Authors:  M Nishikai; M Reichlin
Journal:  Arthritis Rheum       Date:  1980-08

6.  A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.

Authors:  L A Love; R L Leff; D D Fraser; I N Targoff; M Dalakas; P H Plotz; F W Miller
Journal:  Medicine (Baltimore)       Date:  1991-11       Impact factor: 1.889

7.  The overall and temporal association of cancer with polymyositis and dermatomyositis.

Authors:  D Zantos; Y Zhang; D Felson
Journal:  J Rheumatol       Date:  1994-10       Impact factor: 4.666

8.  Elevated cancer incidence in patients with dermatomyositis: a population based study.

Authors:  A Airio; E Pukkala; H Isomäki
Journal:  J Rheumatol       Date:  1995-07       Impact factor: 4.666

Review 9.  Myositis and malignancy.

Authors:  J P Callen
Journal:  Curr Opin Rheumatol       Date:  1994-11       Impact factor: 5.006

  9 in total
  2 in total

Review 1.  Dermatomyositis and colorectal cancer: a systematic review.

Authors:  Ioannis D Gkegkes; Evelyn E Minis; Christos Iavazzo
Journal:  Ir J Med Sci       Date:  2017-11-22       Impact factor: 1.568

Review 2.  Malignancy in patients with inflammatory myopathy.

Authors:  Rachelle Buchbinder; Catherine L Hill
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.